Emergent Biosolutions (EBS)'s 30-day implied volatility (IV30) was 52.7% at the close on November 9, 2026, down from 66.3% the day before, against a 52-week range of 40.2% to 119.2%. Its 20-day historical volatility was 68.9%.
Data as of November 9, 2026.